Are Coles shares a great blue chip investment?

Let's see what Bell Potter is saying about the supermarket giant.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • Bell Potter sees an opportunity to invest in Coles Group, highlighting its strong first-quarter performance and potential for growth.
  • Coles reported solid revenue growth and e-commerce expansion, with continued benefits from supply chain improvements surpassing expectations.
  • Maintaining a buy rating, Bell Potter anticipates a 10% share price upside and a 4% dividend yield, with strategic initiatives supporting a positive outlook.

If you want to add some quality to your portfolio, then Coles Group Ltd (ASX: COL) shares could be a great option.

That's because Bell Potter believes that share price weakness on Thursday has given investors an opportunity to buy this blue chip at an attractive price.

Happy woman looking for groceries. as she watches the Coles share price and Woolworths share price on her phone

Image source: Getty Images

What is the broker saying?

Bell Potter was pleased with the company's performance during the first quarter of FY 2026.

It notes that supermarket sales came in a touch higher than it expected and largely in line with consensus estimates at $9,965 million. It said:

Revenue growth of +4.8% YOY to $9,965m, compared to our $9,925m forecast (and VA of $9,973m). Growth in the early part of 2Q26e has continued at rates comparable to 1Q26 and this compares to the +4.9% YOY growth recorded in the first eight weeks of the quarter. Outperformance relative to the sector seen in 4Q25-1Q26 looks to be continuing, though we are cognisant that COL benefited by ~$120m in late-2Q25 from WOW supply chain disruptions and this needs to be cycled in the coming period. E-commerce sales grew +27.9% YOY reaching 13.3% of sales, with growth within the recently commissioned CFC's outpacing this growth rate.

And while its liquor business continues to struggle in a challenging category, its sales were roughly as expected for the quarter. It adds:

Liquor revenue down -1.1% YOY at $842m (BPe $847m and VA $851m), with three net store closings in the period. E-commerce sales grew +7.6% YOY reaching 7.6% of sales. The category remains challenging.

Time to buy

According to the note, the broker has retained its buy rating and $24.30 price target on Coles shares.

Based on its current share price of $22.11, this implies potential upside of 10% for investors over the next 12 months.

In addition, Bell Potter is forecasting a fully franked dividend of 89.3 cents per share in FY 2026. This would mean a dividend yield of 4%, which stretches the total potential return to 14%.

Overall, the broker remains positive on Coles' outlook thanks to its cost savings, strengthening consumer backdrop, and investments in distribution centre automation. It said:

Our Buy rating is unchanged. Continued delivery against 'Simplify & Save' initiatives ($565m delivered to date vs. a target of $1Bn by FY27e), generating a return on ADC/CFC investments (~$1.45Bn investment and $103m of start-up costs in FY25) and a strengthening consumer backdrop are all reasons for our favourable view. While COL is trading at a premium to historical average (~8.6x FWD EBITDA) and a premium to WOW, COL has continued to outperform WOW at the top line over 4Q25- 1Q26 and into the early stages of 2Q26e.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Blue Chip Shares

A woman reclines in a comfortable chair while she donates blood holding a pumping toy in one hand and giving the thumbs up in the other as she is attached to a medical machine to collect her blood donation.
Blue Chip Shares

Why CSL shares could be one of the best buys on the ASX right now

CSL shares have been hammered by earnings disappointments. But the long-term investment case remains strong.

Read more »

A happy elderly couple enjoy a cuppa outdoors as the woman looks through binoculars.
Blue Chip Shares

The ageing Australia megatrend: 3 ASX shares built to benefit

With an ageing population, Australian companies must position themselves to provide services made for this demographic. These three stocks have…

Read more »

Workers inspecting a gas pipeline.
Dividend Investing

This overlooked ASX stock has raised its dividend 20 years in a row

20 years of consistent dividend growth is just the tip of the iceberg for this quality business.

Read more »

Person handing out $50 notes, symbolising ex-dividend date.
Blue Chip Shares

Where I'd invest $10,000 into ASX 200 dividend shares right now

These businesses look like compelling buys today.

Read more »

A smiling woman with a handful of $100 notes, indicating strong dividend payments
Retail Shares

3 ASX retail shares exposed to a drop in consumer spending

Which stocks could be most impacted by a drop in consumer spending?

Read more »

A target on a red background surrounded by white arrows pointing to it.
Blue Chip Shares

2 high-quality ASX 200 shares experts rate as buys

Experts say these businesses are undervalued.

Read more »

Man with virtual white circles on his eye and AI written on top, symbolising artificial intelligence.
Blue Chip Shares

Why this ASX 200 blue-chip share could be an AI winner

Some companies sell AI tools. Others may create value by applying them across large customer bases and complex operations.

Read more »

A bland looking man in a brown suit opens his jacket to reveal a red and gold superhero dollar symbol on his chest.
Blue Chip Shares

1 ASX blue chip stock I'd consider buying with the ASX 200 around 8,700

This healthcare business has exposure to a large underdiagnosed market, strong recent momentum, and a growing digital ecosystem.

Read more »